🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study objective of this open label, multicenter study is to provide acc...
Status
Completed
Location
Investigator Site - Los Angeles
Start Date
2011-10
Trial ID
NCT01457118
Treatments Being Tested
The purpose of this research study is to evaluate the effect of NKTR-102 on...
Status
Completed
Location
American Institute of Research, Los Angeles
Start Date
2014-02
Trial ID
NCT01976143
Treatments Being Tested
This Phase 2 study is designed to characterize the objective response rate ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2013-01
Trial ID
NCT01773109
Treatments Being Tested
High Grade Gliomas, including anaplastic astrocytomas, anaplastic oligodend...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2012-07
Trial ID
NCT01663012
Treatments Being Tested
The purpose of this clinical trial is to evaluate the safety and tolerabili...
Status
Completed
Location
The fifth medical center of PLA general hospital
Start Date
2018-05-04
Trial ID
NCT04366648
Treatments Being Tested
The purpose of this clinical trial is to evaluate the safety, tolerability ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-11-11
Trial ID
NCT05158491
Treatments Being Tested
This phase II trial studies how well pegylated irinotecan NKTR 102 works in...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-08-29
Trial ID
NCT01876446
Treatments Being Tested
The study is designed as an open-label, randomized, parallel, two arm, mult...
Status
Completed
Location
Arizona Oncology Associates, PC - NAHOA
Start Date
2011-12
Trial ID
NCT01492101
Treatments Being Tested
This is a multicenter, open-label, two-arm, 2-stage, Phase 2 study of NKTR-...
Status
Completed
Location
Investigator Site - Higland
Start Date
2008-10
Trial ID
NCT00806156
Treatments Being Tested
Study 07-PIR-02 is a Phase 2 study designed to evaluate the safety and effi...
Status
Completed
Location
Investigator Site - Scottsdale
Start Date
2008-02
Trial ID
NCT00598975
Treatments Being Tested